CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About CADTH What We Do Programs and Services CADTH Common Drug Review Reports Insulin detemir

Insulin detemir

Last Updated: March 10, 2009

Result type: Reports

Project Number: S0160

Product Line: Common Drug Review

Generic Name: Insulin detemir

Brand Name: Levemir

Manufacturer: Novo Nordisk Canada Inc.

Indications: Diabetes mellitus

Submission Type: Resubmission 2

Project Status: Complete

Date Recommendation Issued: August 20, 2009

Recommendation Type: Do not list

Insulin detemir

Files